Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2012 - 2026)

Gilead Sciences (GILD) has 12 years of Non-Current Deferred Tax Liability data on file, last reported at $392.0 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 44.71% year-over-year to $392.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $392.0 million (down 44.71% YoY) and the FY2025 annual result came in at $402.0 million, down 90.73% from the prior year.
• Non-Current Deferred Tax Liability retreated to $392.0 million in Q1 2026, from $402.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $6.1 billion in Q4 2022 to a low of $392.0 million in Q1 2026.
• A 5-year average of $2.0 billion and a median of $1.6 billion in 2023 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability soared 173.05% — and 2025, when it slumped 90.73%.
• Tracing GILD's Non-Current Deferred Tax Liability over 5 years: stood at $6.1 billion in 2022, then sank by 74.06% to $1.6 billion in 2023, then soared by 173.05% to $4.3 billion in 2024, then slumped by 90.73% to $402.0 million in 2025, then slipped by 2.49% to $392.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $392.0 million (Q1 2026), $402.0 million (Q4 2025), and $597.0 million (Q3 2025), per Business Quant data.